Venrock Spray
NDC Package 85772-0002-1
Package Information
Venrock (piroctone olamine and salicylic acid) sprays is shake well before useApply to affected areas one to four times daily or as directed by a doctorFor best results, use at least twice a week or as directed by a doctorApplication: Hold 15-20 cm (4-6 inches) from dry scalp and spray onto affected areas. This formulation utilizes a spray delivery system. Marketed by Guangzhou Oupeng Cosmetics Co., Ltd., this product is identified by NDC 85772-0002 and is authorized under FDA application M032.
Identification & Billing
- RxCUI: 2717186 - piroctone olamine 0.5 % / salicylic acid 1.5 % Topical Spray
- RxCUI: 2717186 - piroctone olamine 5 MG/ML / salicylic acid 15 MG/ML Topical Spray
Clinical Specifications
- Cutaneous - Administration to the skin.
- Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Regulatory & Marketing
Hierarchy Structure
- 85772 - Guangzhou Oupeng Cosmetics Co., Ltd.
- 85772-0002 - Venrock
- 85772-0002-1 - 1 g in 1 BOX
- 85772-0002 - Venrock
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 85772-0002-1 identifies a specific commercial package of 1 g in 1 box of Venrock, a human over the counter drug labeled by Guangzhou Oupeng Cosmetics Co., Ltd.. This spray is formulated for cutaneous; topical use and contains piroctone olamine; salicylic acid as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Guangzhou Oupeng Cosmetics Co., Ltd. on June 20, 2025. The current certification is valid through December 31, 2026.
How is this Guangzhou Oupeng Cosmetics Co., Ltd. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 85772000201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.